Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharming Group N.V (PHAR) Operating Expenses: 2018-2024

Historic Operating Expenses for Pharming Group N.V (PHAR) over the last 7 years, with Dec 2024 value amounting to $153.8 million.

  • Pharming Group N.V's Operating Expenses fell 24.01% to -$87.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $66.0 million, marking a year-over-year decrease of 15.25%. This contributed to the annual value of $153.8 million for FY2024, which is 23.24% up from last year.
  • As of FY2024, Pharming Group N.V's Operating Expenses stood at $153.8 million, which was up 23.24% from $124.8 million recorded in FY2023.
  • In the past 5 years, Pharming Group N.V's Operating Expenses registered a high of $153.8 million during FY2024, and its lowest value of $62.6 million during FY2020.
  • Moreover, its 3-year median value for Operating Expenses was $124.8 million (2023), whereas its average is $125.7 million.
  • In the last 5 years, Pharming Group N.V's Operating Expenses skyrocketed by 71.51% in 2021 and then decreased by 8.22% in 2022.
  • Yearly analysis of 5 years shows Pharming Group N.V's Operating Expenses stood at $62.6 million in 2020, then spiked by 71.51% to $107.4 million in 2021, then dropped by 8.22% to $98.5 million in 2022, then climbed by 26.63% to $124.8 million in 2023, then rose by 23.24% to $153.8 million in 2024.